In March 2022, IVEN signed the first US turnkey project, that means IVEN is the first Chinese pharmaceutical engineering company to undertake a turnkey project in the US in 2022. It’s also a milestone that we have successfully expanded our pharmaceutical engineering project business to the US.

Thanks for customer’s trust. The recognition of our US customers is also due to our years of experience in the pharmaceutical industry and our professional industry knowledge.